Articles by Fedra Pavlou - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Fedra Pavlou

Fedra Pavlou


Fedra Pavlou is the former editor-in-chief of Pharmaceutical Technology Europe.

Articles
It's Goodbye From Me
March 7, 2011

This issue will mark the last issue for me as Editor of PTE. It's time for me to move on to pastures new and to say my goodbyes.

Your chance to be published in PTE!
February 16, 2011

Want to take part in Pharm. Tech. Europe's roundtable on tabletting and stand a chance of seeing your opinion published in a magazine that reaches 18,000 professionals across Europe?

Trade show trade down?
February 11, 2011

I can't remember a day go by in the last few years when I haven't received an email or item of mail inviting me to attend a conference or trade event

Should We Back DTC in Europe?
January 7, 2011

This month, our columnist Nathan Jessop discusses a topic that remains highly debated in Europe; direct to consumer (DTC) advertising.

A year of ups and downs
December 1, 2010

So 2010 is nearly over and what a year it's been for our industry.

Lessons in efficiency
November 1, 2010

I recently attended the annual CPhI exhibition in Paris, which turned out to be a great event for the PTE team and I.

Green is the word
October 1, 2010

Every day we are exposed to messages of advice and guidance on what we can do to reduce the damaging effects that our lifestyles have on the environment.

Approach social media with caution?
September 1, 2010

No one can deny the power of social media; it has revolutionised communication and empowered consumers, creating a medium that allows the free flow of information with no authority to control it.

Continuous Processing: Is The Pharma Industry Finally Coming Round To The Idea?
September 1, 2010

Industry experts discuss the merits of continuous processing technology and explain why pharma manufacturers should realize the benefits these technologies offer.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here